JP2002539161A - トロポニンサブユニット、それらの断片および相同体を含む医薬組成物ならびに血管形成を抑制するためのそれらの使用方法 - Google Patents

トロポニンサブユニット、それらの断片および相同体を含む医薬組成物ならびに血管形成を抑制するためのそれらの使用方法

Info

Publication number
JP2002539161A
JP2002539161A JP2000604846A JP2000604846A JP2002539161A JP 2002539161 A JP2002539161 A JP 2002539161A JP 2000604846 A JP2000604846 A JP 2000604846A JP 2000604846 A JP2000604846 A JP 2000604846A JP 2002539161 A JP2002539161 A JP 2002539161A
Authority
JP
Japan
Prior art keywords
hutni
peptide
seq
amino acid
troponin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000604846A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002539161A5 (enExample
Inventor
ソーン，リチャード，エム．
ランサー，マーク，イー．
モーゼス，マーシャ，エー．
ウィエダースチェイン，デミトリ，ジー．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/442,099 external-priority patent/US6465431B1/en
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of JP2002539161A publication Critical patent/JP2002539161A/ja
Publication of JP2002539161A5 publication Critical patent/JP2002539161A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2000604846A 1999-03-15 2000-03-14 トロポニンサブユニット、それらの断片および相同体を含む医薬組成物ならびに血管形成を抑制するためのそれらの使用方法 Pending JP2002539161A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26827499A 1999-03-15 1999-03-15
US09/442,099 1999-11-17
US09/442,099 US6465431B1 (en) 1999-11-17 1999-11-17 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
US09/268,274 1999-11-17
PCT/US2000/006667 WO2000054770A1 (en) 1999-03-15 2000-03-14 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis

Publications (2)

Publication Number Publication Date
JP2002539161A true JP2002539161A (ja) 2002-11-19
JP2002539161A5 JP2002539161A5 (enExample) 2007-01-25

Family

ID=26952984

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000604846A Pending JP2002539161A (ja) 1999-03-15 2000-03-14 トロポニンサブユニット、それらの断片および相同体を含む医薬組成物ならびに血管形成を抑制するためのそれらの使用方法

Country Status (5)

Country Link
EP (1) EP1165059A4 (enExample)
JP (1) JP2002539161A (enExample)
AU (1) AU774596B2 (enExample)
CA (1) CA2367611A1 (enExample)
WO (1) WO2000054770A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007526763A (ja) * 2004-01-27 2007-09-20 コンピュゲン エルティーディー． 新規のヌクレオチドおよびアミノ酸配列、ならびにそれらを心臓疾患の診断に用いるアッセイおよび方法
JP2011020943A (ja) * 2009-07-14 2011-02-03 Kyushu Univ トロポニン含有医薬組成物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1619498B1 (en) * 2003-04-16 2011-01-05 Ono Pharmaceutical Co., Ltd. Method of screening remedy for heart disease and medicinal composition for treating heart disease
WO2010010153A1 (en) * 2008-07-23 2010-01-28 F. Hoffmann-La Roche Ag Identification of subjects being susceptible to anti-angiogenesis therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030085A1 (en) * 1996-02-16 1997-08-21 Children's Medical Center Corporation Troponin subunits and fragments useful as angiogenesis inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030085A1 (en) * 1996-02-16 1997-08-21 Children's Medical Center Corporation Troponin subunits and fragments useful as angiogenesis inhibitors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007526763A (ja) * 2004-01-27 2007-09-20 コンピュゲン エルティーディー． 新規のヌクレオチドおよびアミノ酸配列、ならびにそれらを心臓疾患の診断に用いるアッセイおよび方法
JP2011020943A (ja) * 2009-07-14 2011-02-03 Kyushu Univ トロポニン含有医薬組成物

Also Published As

Publication number Publication date
CA2367611A1 (en) 2000-09-21
EP1165059A4 (en) 2003-03-05
WO2000054770A1 (en) 2000-09-21
EP1165059A1 (en) 2002-01-02
AU3744900A (en) 2000-10-04
AU774596B2 (en) 2004-07-01
WO2000054770A8 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
US6465431B1 (en) Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
CA2247247C (en) Troponin subunits and fragments useful as angiogenesis inhibitors
US20090156491A1 (en) Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit i
RU2304585C2 (ru) Очищенный иммуногенный белок, его фрагменты и производные
US7563596B2 (en) Method of modulating tissue growth using Frzb protein
JP2007537260A (ja) 眼細胞生存の促進におけるラクリチンの使用
US20080051345A1 (en) Pharmaceutical compositions comprising fragments and homologs of troponin subunits
CN1367791A (zh) 一种新的血管发生抑制剂
US7223733B2 (en) Modulation of TRIP-Br function and method of treating proliferative disorders
JP2002539161A (ja) トロポニンサブユニット、それらの断片および相同体を含む医薬組成物ならびに血管形成を抑制するためのそれらの使用方法
US7049291B2 (en) Isolation and method of using tissue growth-inducing Frzb protein
CN109593123A (zh) 一种衍生自rps23rg1的多肽及其应用
US20030119747A1 (en) Methods of using pharmaceutical compositions comprising troponin subunits and homologs thereof before, during, or after surgical resection or radiologic ablation of a solid tumor
KR20040086708A (ko) Ｙｈ 모티프를 포함하는 펩타이드를 유효성분으로함유하는 혈관신생 억제제
EP1098971A2 (en) Myotilin, an actin-organizing protein
US20040249140A1 (en) Transcription factors that regulate normal and malignant cell growth
JP2003219889A (ja) 新規ｍａｐキナーゼ活性抑制因子
FR2827773A1 (fr) Composition pour la regulation negative de l'activite tyrosine kinase des proteines src et analogues, et applications
DE29724845U1 (de) Pharmazeutische Zusammensetzung mit Angiogenese-Inhibitoren

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080828

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091215

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100309

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100316

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101102